Technical
Channels

Drug Discovery

Drug Development

Drug Manufacturing

Drug Delivery

Clinical Trials

Regulatory and Legal

Alliances and Mergers

QA/QC and Compliance

Pharmaceutical Processing and Packaging

Drug Delivery

Search Results 11 - 20 of 145 records

Nycomed and Merck & Co Announce Commercialization Agreements in Europe and Canada

(Business News, 29 Apr 2010 )

Nycomed and Merck & Co have entered into a co-promotion agreement for Canada and certain European countries for the commercialization of Daxas (roflumilast), an investigational once-daily tablet for patients ....


Healthcare in Asia: Keeping Pace

(Conference Summary, 29 Apr 2010 )

Healthcare in Asia was held in Singapore on March 30-31, to debate and explore the region's healthcare challenges, and the priorities for reform. The event was attended by 200 visitors including healthcare ....


Elder Pharmaceuticals to Increase Sales Force in India

(Business News, 23 Apr 2010 )

With major thrust on the rural markets and plans to launch more products (owned and in-licensed) in FY 2011 across India, Elder Pharmaceuticals plans to increase its sales and marketing force headcount ....


Watson Receives Approval for Heart Failure Drug

(Business News, 22 Apr 2010 )

Watson Laboratories has received approval from the US Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for metoprolol succinate extended-release tablets USP in the 100 ....


Avita Medical to Distribute "Spray-On Skin" in Taiwan

(Business News, 22 Apr 2010 )

Avita Medical has secured regulatory approval for its ReCell autologous spray-on skin from the Taiwan Ministry of Health. The target market for the product includes plastic and reconstructive surgeons, ....


Genetic Technologies Acquires Beast Cancer Risk Test

(Business News, 19 Apr 2010 )

Genetic Technologies has acquired certain assets from US-based Perlegen Sciences, with the main asset being the BrevaGen breast cancer risk test. In addition to the test, GTG has acquired a suite of granted ....


Healthcare Adapts to "New Normal" with Ariba

(Business News, 16 Apr 2010 )

Supply market volatility. Capacity constraints. Global uncertainty. They are the reality of doing business in the New Normal that all companies must deal with. Add to this, calls for reform, regulatory ....


Invida Inaugurates Corporate Headquarters in Singapore

(Business News, 02 Apr 2010 )

Singapore-based transnational company, Invida Group, has reaffirmed its commitment to the Asia Pacific region. The company announced, at the inauguration of its corporate headquarters, the expansion of ....


Drug Companies Enter Indonesia and the Philippines

(Top News, 01 Apr 2010 )

An increasing number of pharmaceutical companies are targeting emerging markets. Indonesia and the Philippines are starting to gain considerable attention, due to their growing healthcare systems. A report ....


Big Pharma Struggles to Benefit from Increased CVD Drug Usage

(Business News, 17 Mar 2010 )

Pharmaceutical (Pharma) companies will struggle to profit from the Cardiovascular Disease (CVD) market over the next decade despite growing drug usage, according to Datamonitor. It is predicted that the ....


Digital Edition



Singapore's Preclinical R&D industry should differentiate itself in Asia by competing on quality rather than on price.
Yes
No
View results


ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US

© 2010 Ten Alps Communications Asia. All rights reserved.
Use of this Web site is subjected to its Terms and Conditions of Use. View our Privacy Policy